"La Polyclinique les Fleurs, située à Ollioules, regroupe plus de 120 médecins spécialistes et une équipe de plus de 300 personnes. Elle possède 190 lits et places. L'établissement propose de très nombreuses spécialités médico-chirurgicales."

During the past decade, Polyclinique les Fleurs conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Polyclinique les Fleurs" #1 sponsor was "Elsan" with 3 trials, followed by "Abbott Medical Devices" with 2 trials sponsored, "Boston Scientific Corporation" with 2 trials sponsored, "Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer" with 2 trials sponsored and "Arterial Remodeling Technologies" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Polyclinique les Fleurs" #1 collaborator was "Abbott" with 2 trials as a collaborator, "Biotronik France" with 1 trials as a collaborator, "Boston Scientific; Pr Olivier Varenne" with 1 trials as a collaborator, "Centre Hospitalier Universitaire de Saint Etienne" with 1 trials as a collaborator and "Corelab ISIT" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Polyclinique les Fleurs" are "Coronary Artery Disease" (7 trials), "Deep Vein Thrombosis" (2 trials), "Acute Coronary Syndrome" (1 trials), "Angioplasty" (1 trials) and "Angioplasty, Balloon" (1 trials). Many other conditions were trialed in "Polyclinique les Fleurs" in a lesser frequency.

Most popular intervention types in "Polyclinique les Fleurs" are "Device" (13 trials), "Procedure" (4 trials), "Drug" (3 trials), "Other" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "ART18Z Bioresorbable stent" (1 trials), "CT scan" (1 trials), "Color Doppler Ultrasound" (1 trials) and "Colour doppler ultrasound with or without D-dimer test" (1 trials). Other intervention names were less common.

The vast majority of trials in "Polyclinique les Fleurs" are 24 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Polyclinique les Fleurs". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Polyclinique les Fleurs, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Polyclinique les Fleurs, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".

Polyclinique les Fleurs has several departments that took part in Clinical trials: "Clinique Montreal; Chimiotherapie" - 3 trials, "Polyclinique Sainte Marguerite; Chimiotherapie" - 2 trials